The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2019

Filed:

Sep. 14, 2016
Applicant:

Signpath Pharma Inc., Quakertown, PA (US);

Inventors:

Laura A. Sordillo, New York, NY (US);

Peter P. Sordillo, New York, NY (US);

Lawrence Helson, Quakertown, PA (US);

Assignee:

Signpath Pharma, Inc., Sandy, UT (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/121 (2006.01); A61K 45/06 (2006.01); A61K 36/9066 (2006.01); A61K 9/127 (2006.01); A61K 31/4188 (2006.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/121 (2013.01); A61K 9/0019 (2013.01); A61K 9/127 (2013.01); A61K 31/4188 (2013.01); A61K 36/9066 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01);
Abstract

The present invention includes a composition and method for treating a glioblastoma in a human or animal subject comprising the steps of: identifying the human or animal subject in need of treatment of a glioblastoma, wherein the human or animal is no longer responsive to at least one of chemotherapy, surgery, or radiation therapy; and administering to the human or animal subject a therapeutically effective amount of a composition comprising: an amount of a curcumin or curcuminoids in one or more liposomes, or curcumin or curcuminoids and empty liposomes and administered prior to, concomitantly, or after administration of the curcumin or curcuminoids, that is effective for treating the glioblastoma, wherein the liposomal curcumin or curcuminoids, or empty liposomes, eliminate the QT prolongation caused by the curcumin or curcuminoids; and at least one chemotherapeutic agent that is synergistic with curcumin to treat the glioblastoma.


Find Patent Forward Citations

Loading…